Taro Pharmaceutical Industries (TARO.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

For Institutions
- Corporate Services
- Developers
Download
Help
About

Markets

Information

Affiliate Program

Promotions

EN

English

简体中文

繁體中文

繁體中文（廣東話）Posts & comments will be shown in Cantonese

Search...

Quote List Quote List

© 2025 Longbridge｜Disclaimer

Event Tracking

May8

Sun Pharmaceutical's acquisition of Taro

13:16

Schedules & Filings

Schedules

Filings

May20

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 164.94 M, Net Income 15.08 M, EPS 0.4011

Jan26

Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 157.15 M, Net Income 20.21 M, EPS 0.5376

Oct26

Earning Release(EST)

FY2024 Q2 Earning Release (USD) Revenue 148.2 M, Net Income 8.547 M, EPS 0.2274

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More